Business ❯Finance ❯Corporate Finance ❯Stock Market

Analyst Ratings

Moderna Reports Larger-Than-Expected Q4 Loss as COVID Vaccine Sales Plummet

The biotech company faces declining demand for its COVID-19 vaccine, a $238M manufacturing charge, and reduced 2025 revenue forecasts.

Biogen Reports Mixed Q4 Results and Lowers 2025 Outlook

Chevron and Exxon Report Mixed Q4 Results with Divergent Trends in Production and Refining

AT&T Exceeds Q4 Expectations with Strong Subscriber Growth and Profit Surge